SCHEMBL3425319

SCHEMBL3425319

Cc1ccc(-c2ccc(Sc3ccc(C(=O)C(C)(C)S(=O)(=O)c4ccc(C)cc4)cc3)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 1/20 0.38
LMNA P02545 2/20 0.38
KDM4E B2RXH2 1/20 0.38
APEX1 P27695 1/20 0.38
HPGD P15428 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MEN1 O00255 2/20 0.37
ALDH1A1 P00352 2/20 0.37
KMT2A Q03164 2/20 0.37
PTGES O14684 1/20 0.37
ALOX5 P09917 1/20 0.37
CYP2C19 P33261 1/20 0.37
PPARG P37231 1/20 0.37
NCOA2 Q15596 1/20 0.37
NCOA1 Q15788 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
CA2 P00918 3/20 0.37
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8669976 0.96 DNMT1 (0.41) DNMT1LMNAKDM4EAPEX1HPGD
SCHEMBL12757096 0.92 LMNA (0.44) DNMT1LMNAKDM4EAPEX1HPGD
SCHEMBL12757101 0.92 CA1 (0.43) LMNAKDM4EAPEX1HPGDMEN1
SCHEMBL195111 0.87 AKR1C3 (0.41) LMNAKDM4EAPEX1HPGDMEN1
SCHEMBL12757093 0.87 LMNA (0.40) DNMT1LMNAKDM4EAPEX1HPGD
SCHEMBL6551010 0.87 LMNA (0.46) LMNAHPGDMEN1ALDH1A1KMT2A
SCHEMBL12757095 0.86 KMT2A (0.42) LMNAL3MBTL1MEN1ALDH1A1KMT2A
SCHEMBL12757102 0.86 LMNA (0.39) DNMT1LMNAKDM4EAPEX1HPGD
SCHEMBL5272382 0.86 ALDH1A1 (0.47) DNMT1LMNAMEN1ALDH1A1KMT2A
SCHEMBL23003257 0.85 RECQL (0.39) LMNAKDM4EAPEX1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7687220-B2 Oxime derivatives and use thereof as latent acids CIBA SPECIALTY CHEMICALS CORPORATION (US) 2010-03-30 US disclosed
US-20080085458-A1 Oxime Derivatives And Use Thereof As Latent Acids CIBA SPECIALTY CHEMICALS CORPORATION 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085458-A1 Oxime Derivatives And Use Thereof As Latent Acids ARSA, CYP2S1, QSOX1 DNMT1 3737/4885LMNA 421/4885KDM4E 2443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.